Aria Torkpour

CellPrior-net: Prior-guided nuclei detection and classification for H&E whole-slide images

Falah Jabar, Pasquale Lombardi, Aria Torkpour, Masoud Tafavvoghi et autres

no, gb, dk (code pays fourni par la source)

CellPrior-Net: Prior-Guided Nuclei Detection and Classification for H&E Whole-Slide Images

Falah Jabar, Pasquale Lombardi, Aria Torkpour, Masoud Tafavvoghi et autres

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma

Pasquale Lombardi, Erik Ramon‐Gil, Rabial Q. Raja, Leonardo Brunetti et autres

it, gb, es, kr, us, at, tw, jp, de, no, be (code pays fourni par la source)

TOP-408-YI Efficacy and feasibility of neoadjuvant immunotherapy in hepatocellular carcinoma

Sarah Cappuyns, Antonio D’Alessio, Pasquale Lombardi, Claudia Fulgenzi et autres

A Review on Artificial Intelligence as a Solution to Burnout in Interventional Radiology

Henry Zhang, Aria Torkpour, Boroumand Zeidaabadi, Nader Ashraf et autres

gb, sa, au, us, fr (code pays fourni par la source)

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

Pei-Chang Lee, Alessio Cortellini, Bernardo Stefanini, Changhoon Yoo et autres

tw, it, gb, kr, jp, at, us, es, de (code pays fourni par la source)

The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study

Mathew Vithayathil, Giulia Francesca Manfredi, Antonio D’Alessio, Claudia Angela Maria Fulgenzi et autres

gb, it, es, de, jp, at, us, tw, ca, kr (code pays fourni par la source)

219P Benchmarking state-of-the-art deep learning models for tumor-infiltrating lymphocytes (TILs) quantification

Masoud Tafavvoghi, Fakher Rahim, Sigve Andersen, Erna‐Elise Paulsen et autres

no, gb, it, dk, us (code pays fourni par la source)

14P Evaluating pathology foundation models for pathologic response assessment in hepatocellular carcinoma (HCC) whole slide images (WSIs) following neoadjuvant immune checkpoint inhibitors (nICIs)

Aria Torkpour, A. D’Alessio, Francesco Mauri, Robert A. Anders et autres

gb, us, gt, tw, it, no (code pays fourni par la source)

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Bernhard Scheiner, Pasquale Lombardi, Antonio D’Alessio, Gwangil Kim et autres

gb, at, it, kr, no, ua, de (code pays fourni par la source)

Clinical and molecular characterisation of primary refractoriness to atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma

Pasquale Lombardi, Erik Ramon‐Gil, Leonardo Brunetti, Giulia Francesca Manfredi et autres

it, gb, kr, us, at, tw, jp, de, no, es (code pays fourni par la source)

187P Neoadjuvant immunotherapy is associated with a recurrence free survival benefit versus active surveillance in patients with resected hepatocellular cancer

Leonardo Brunetti, A. D'Alessio, Claudia Angela Maria Fulgenzi, Mark Yarchoan et autres

gb, us, gt, tw (code pays fourni par la source)